Blogs & News Articles

1933 Industries (CSE: TGIF- OTCQB: TGIFF) CEO Paul Rosen joined Steve Darling from Proactive to bring news the company has completed their recent oversubscribed financing bringing in over 5 million dollars.

Rosen sharing with Proactive this capital along with some work on the balance sheet has put the company in a much better position. Rosen also talking about some things they plan on doing to help with yields from their operations.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

Continue reading

The two companies will work together to jointly market the 3 Rivers offering to growers and eventually provide access to other commercial-ready solutions in pest control, pathogen testing and genetic fingerprinting

PTC involves growing a plant from a small number of cells, rather than from seeds or clones, under strictly controlled sterile conditions in a nutrient medium

Australis Capital Inc (CSE:AUSA) (OTCMKTS:AUSAF) (FRA:AC4) is teaming up with agricultural technology company 3 Rivers Biotech Inc on a tissue culture joint venture, the company announced Wednesday. 

3 Rivers specializes in commercial-scale micropropagation, or plant tissue culture (PTC), for cannabis, hemp and traditional crops. 

The two companies will work together to jointly market the 3 Rivers offering to growers and eventually provide access to other commercial-ready solutions in pest control, pathogen testing and genetic fingerprinting. 

READ: Australis Capital buys 51% stake in cannabis facility design/construction company ALPS

Under the terms of the partnership, Australis will own 15% and 3 Rivers will own 85% of the joint venture. 3 Rivers will provide access to its intellectual property and services, products and solutions to Australis-sourced clients through the joint venture.

Continue reading

The company's 3Q results were impacted by a number of non-cash impairment charges against legacy assets and operations that do not feature heavily in its future trajectory

The firm’s investments in BAMM and Quality Green are up by about $7 million

() () (FRA:AC4) reported its third quarter 2021 results on Monday evening that saw the company end a transformational period with $7.6 million in cash. 

Revenue for the quarter came in at $90,000, consisting of consulting fees from BAMM and technology revenue from its Cocoon business, both legacy businesses that do not feature heavily in the Las Vegas-based company’s future plans. 

In a statement accompanying the results, the cannabis company said it was “positioned for rapid growth” following the closing of two major transactions to acquire cultivation facility construction firm ALPS and Green Therapeutics, a Nevada-based cannabis company. 

READ: Australis Capital buys 51% stake in cannabis facility design/construction company ALPS

Australis plans to leverage an ALPS-driven expansion model to scale up the Green Therapeutics brands throughout the US after both deals close by the end of March.

Continue reading

Since its management buyout from Aurora Cannabis in May 2020, ALPS has built a blue-chip roster of global customers and a growing pipeline of potential new deals

Australis will pay between C$13.7 million and nearly C$26 million in total consideration, the company said

Australis Capital Inc (CSE:AUSA) (OTCMKTS:AUSAF) (FRA:AC4) has reached a definitive agreement to acquire 51% of the issued and outstanding shares of cannabis facility design company ALPS, the company announced Wednesday. 

Australis will pay between C$13.7 million and nearly C$26 million in total consideration, the company said. Initially, the company will pay C$10 million in either common shares at a price of C$0.20, cash, or a mixture of both. An additional C$2 million will be paid once the deal closes, and a C$1.7 million indemnity holdback to follow after 18 months.  

The agreement also has an option for Australis to acquire the remaining 49% within three years. If sufficient milestone payments are made (the maximum milestone payment is $24 million in three installments if ALPS hits cumulative revenues of C$108.7 million and EBITDA of C$48.9 million), the payments will count in part toward that option.  

READ: Australis Capital says nearing completion of its acquisitions of ALPS and Green Therapeutics

Since its management buyout from Aurora Cannabis in May 2020, ALPS has built a blue-chip roster of global customers and a growing pipeline of potential new deals, the company said. ALPS is currently executing on a number of contracts, including Aurora, Cann Group, Vertical Harvest and Aldershot Greenhouses.

Continue reading

The company said Propagation Services Canada, its flagship cultivation asset, is continuing its momentum towards first commercial sales

The first commercial crop for sale will include three proprietary strains - Mimosa 37, Kosher Kush, and Gelato

AgraFlora Organics International Inc () (FRA:PU31) (OTCPINK:AGFAF) has said Propagation Services Canada Inc (PSC), its flagship cultivation asset located in Delta, British Columbia, is continuing its momentum towards first commercial sales and is expected to report initial revenues in the summer of 2021.

The cannabis firm noted that the first commercial crop for sale will include three proprietary strains - Mimosa 37, Kosher Kush, and Gelato - which it said have been selected for their strong demand in Canada’s dried flower market, as well as their growing attributes within the greenhouse environment which align with their low-cost high-THC cannabis attributes.

READ: AgraFlora Organics expects to enter Canadian edibles market in 1Q 2021

AgraFlora added that PSC has gathered valuable data from crops grown to date and continues to “develop and strategize to further aid in its positioning as a leader in low-cost product”.

The firm also said recent modifications and calibrations provided by an international partner to existing drying rooms have allowed PSC to almost double anticipated drying capacity for a minimal investment, and that PSC will be optimizing its propagation operations by fine-tuning its climate strategy to produce healthy, rooted cuttings more quickly with high success rate monitoring irrigation mixtures to produce custom nutrient formulations for each stage of plant growth.

Continue reading
Focused on building companies through early-stage, opportunistic, and diversified investments in cannabis space Spun off from Aurora Cannabis in late 2018 Terry Booth, who helped build Aurora, slated to become CEO of Australis

() () aims to build companies through early-stage, opportunistic, and diversified investments in the cannabis value chain in the US and abroad.

The Nevada-based company’s business and assets include investments in Cocoon Technology LLC, , Green Therapeutics LLC, Quality Green, Folium Biosciences, and land assets in Washington state and Michigan. 

Australis was spun out from cannabis behemoth Aurora Cannabis Inc (TSE:ACB) (NYSE:ACB) in September 2018 as its US investment vehicle. Aurora is not allowed to invest in US cannabis assets due to Toronto Stock Exchange and NYSE listing rules. Australis is therefore Aurora’s arm to establish a foothold in the US, before a potential US federal legalization shift.

As part of the new strategy to scale up its award-winning brands across the US and global cannabis markets, the company is seeking a 51% interest in cash-flow-healthy ALPS - the world’s premier design, construction management, commissioning, and post-commissioning consultancy for horticultural crops such as cannabis. Australis is also seeking 100% acquisition of the outstanding membership interest in Nevada-based cannabis cultivator Green Therapeutics (GT).

But the ALPS acquisition - expected to close in late February 2021 - is central to the company’s new growth blueprint. 

Continue reading

The company is seeking a 51% interest in ALPS and the 100% acquisition of the outstanding membership interest in Green Therapeutics

Meanwhile, Terry Booth is expected to be appointed as CEO of Australis upon completion of the acquisition of ALPS

() () said Tuesday it is progressing well towards the completion of its proposed acquisitions of ALPS and Green Therapeutics LLC (GT).

Australis is seeking a 51% interest in ALPS and the 100% acquisition of the outstanding membership interest in Green Therapeutics, which includes the discontinuation of all previous litigation with Green Therapeutics. 

“As per the Company's commitment to keep our shareholders fully informed and apprised, we are expecting to enter into definitive agreements with ALPS in short order,” the Nevada-based company said in a statement.

READ: Australis Capital acquiree ALPS inks deal to build a high-tech California greenhouse

Continue reading

The company said it has never been in a better position to achieve sustainable and profitable top line revenue growth going forward

1933 Industries says it expects to generate increased revenues and improved margins with higher volume, quality and consistency of saleable flower and biomass produced

1933 Industries Inc (CSE:TGIF) (OTCQB:TGIFF) reported that its company-wide total sales and open orders reached C$1.4 million in January, which it called a “significant milestone” as 1933 continues to scale-up production from its state-of-the-art Las Vegas cultivation facility. 

The company also noted that its Alternative Medicine Association (AMA) cultivation subsidiary saw its revenue surge 113% increase year over year, which represents its strongest monthly sales to date since launching its AMA branded cannabis flower and pre-rolls in late August 2020.

“As seasoned operators, we are pleased with the progress to date and we believe that the company has never been in a better position to achieve sustainable and profitable top line revenue growth going forward,” 1933 Industries CEO Paul Rosen said in a statement.

READ: 1933 Industries expects stronger finances in fiscal 2021 as it looks to grow Nevada market share

He added: “Our execution strategy is completely aligned with our shareholders as we continue to build the business, utilizing our competitive advantages in operating large-scale cultivation to solidify a dominant position within our core market.”  

Continue reading

Australis said the greenhouse facility is expected to save up to 90% on water use and 90% on labour compared to a traditional farm

The California greenhouse is expected to grow 48 million pounds of produce on a footprint 1/30th the size of a traditional farm

 () () (FRA:AC4) reported that ALPS, a company in which Australis is in the process of acquiring, has entered into an agreement with Bluehouse Greenhouse (BHGH) for the development of a 62 acre (2.7 million square foot), high-tech, fully integrated greenhouse for the sustainable production of vegetables in California. 

Australis said the greenhouse facility, which will be developed by ALPS’ wholly-owned subsidiary Larssen Greenhouse Consulting (LGC), is expected to save up to 90% on water use and 90% on labour while growing 48 million pounds of produce on a footprint 1/30th the size of a traditional farm.  

“With this sizeable $1.9 million project, ALPS continues to capitalize on opportunities and grow revenues at a rapid pace,” AUSA Interim CEO Dr. Duke Fu said in a statement. 

READ: Australis Capital unveils significant expansion moves with plans to acquire both Green Therapeutics and ALPS

He added: “Conversion of ALPS's substantial business development pipeline in both the cannabis and traditional horticulture sectors will provide AUSA, once the acquisition is completed, with cash flow to further fuel the execution of its capital-light expansion strategy.”

Continue reading

The agreement for the 363,000 square foot facility includes the installation of a computerized compliance and maintenance management system, APIS

Australis announced its intention to acquire 51% of ALPS in January 2021, with an option to purchase the remaining 49%

() () (FRA:AC4) announced Tuesday its acquisition target ALPS inked an agreement with Cann Group Limited to deliver end-to-end design, construction and commissioning services for the latter’s planned Australian greenhouse. 

The $2.5 million agreement for the 363,000 square foot facility includes the installation of a computerized compliance and maintenance management system, APIS, and an ongoing service contract, the company said in a statement. 

ALPS is a leading design, construction management, commissioning and post commissioning consultancy company for horticultural crops. The company has been involved in cannabis projects across the globe with a total grow area in excess of 340 acres for a total cultivation capacity of around 2,000,000 kilograms of cannabis per year.

READ: Australis Capital unveils significant expansion moves with plans to acquire both Green Therapeutics and ALPS

"This is a significant contract for us in terms of size, and acknowledges the respect ALPS has garnered in the global cannabis space,” ALPS president Thomas Larssen said in a statement accompanying the news.

Continue reading

Australis Capital's pending acquisitions of Green Therapeutics LLC and ALPS is part of its shift from an investment company into a US multi-state operator

Australis Capital says it expects its recent acquisitions will result in meaningful revenue growth and profitable operations

Australis Capital Inc (CSE:AUSA) (OTCMKTS:AUSAF) (FRA:AC4) provided an operations update on its pending acquisitions of Green Therapeutics LLC and ALPS, as part of its shift from an investment company into a US multi-state operator (MSO).   

Australis said Green Therapeutics (GT) saw a record 47% year-over-year increase in December sales, and recently reached an agreement to sell its land in North Las Vegas, which would result in AUSA receiving approximately US$1.95 million if the transaction is completed.

Meanwhile ALPS, through its wholly-owned subsidiary Larssen Greenhouse Consulting (LGC), has executed a number of contracts for the development of facilities for the cultivation of high-quality, low-cost crops such as fruits, vegetables and microgreens.

READ: Australis Capital unveils significant expansion moves with plans to acquire both Green Therapeutics and ALPS 

“The new board is rapidly changing AUSA from an ‘investment’ company into a multi-state operator with expected meaningful revenue growth, resulting in profitable operations,” Australis Capital CEO designate Terry Booth said in a statement.

Continue reading

Australis Capital (CSE: AUSA- OTC: AUSAF) new CEO Terry Booth joined Steve Darling from Proactive with news the company is planning to utilize a new strategy for the company as they look to capitalize on a number of opportunities.

Booth shared with Proactive what that strategy will be and how he plans on measuring performance and making sure they are accountable to shareholders.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

Continue reading

The development phase of the R&D trials is complete and the company has created efficient processes for desired formulations and products (gummies) as it prepares to go commercial

The edibles facility will utilize its current state of the art laboratory set up to produce about 60,000 pieces per eight-hour shift

AgraFlora Organics International Inc () (FRA:PU31) (OTCPINK:AGFAF) said Wednesday it expects to enter the Canadian edibles market in the first quarter of 2021. 

In a statement, the company said it has completed the first phase of research and development trials at its Health Canada-licensed, 51,000 square-foot, fully automated edibles manufacturing facility in Winnipeg, Manitoba. 

Prior to receiving a standard processing license from Health Canada, the company had commenced cultivating long-term production relationships through R&D trials utilizing the company’s Health Canada R&D license. 

READ: AgraFlora Organics receives cannabis edibles processing licence for its Winnipeg manufacturing facility

And now that the development phase of the R&D trials is now complete and the company has created efficient processes for desired formulations and products, AgraFlora said it is nearly prepared to enter the edibles market soon.  

Continue reading

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires

PyroGenesis Canada Inc () (OTCQB:NYRNF) CEO Peter Pascali will present at the SNN Network Canada virtual event on Thursday January 7 at 10:30am ET. To access the live presentation, viewers may visit https://www.webcaster4.com/Webcast/Page/2059/39297. Investors may also book one on one meetings with Pascali by registering at https://canada.snn.network/signup.

has published a two-part management series on (NASDAQ: BLNK), which focuses on the company’s key drivers, milestones, obstacles and opportunities, and industry megatrends featuring Blink’s CEO Michael Farkas. Water Tower Research’s management series covers key catalysts and milestones that investors should monitor, including network expansion opportunities through joint ventures (JVs) and long-term partnership agreements, additional charger deployments with Envoy Technologies, and additional geographic expansion.

() (OTCQB:VLMGF) announced Wednesday it has entered into an exploration earn-in agreement with a wholly owned subsidiary of Centerra Gold Inc (). Centerra is a Canadian-based gold mining company focused on operating, developing, exploring and acquiring gold properties in North America, Asia and other markets worldwide and is one of the largest Western-based gold producers in Central Asia. Viscount said the agreement covers the company's Cherry Creek property located in White Pine County, Nevada. Initially, Viscount will be the project manager. The Cherry Creek project is located in northeastern Nevada some 50 miles north of Ely, consisting of 320 unpatented and patented claims covering more than 2,658 hectares. The property contains more than 20 past-producing mines where high-grade gold and silver production came from up to the 1920s.

True Leaf Brands Inc () (OTCPINK:TRLFD) (FRA:TLA) is proposing a non-brokered private placement offering to raise gross proceeds of not less than C$150,000 up to C$1 million. Under the terms, the company will offer for sale a minimum of 416,667 common shares up to a maximum of 2,777,778 common shares at C$0.36 per share. The offering may close in one or more tranches on or before January 31. The company anticipates utilizing the net proceeds of the placement for working capital and general corporate purposes.

Continue reading

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires

Wellness Inc (), a leading US health and wellness CBD company, announced that it has completed its initial public offering (IPO) to raise US$17 million and has started trading on the big board in Toronto. The company rounded out its US$17 million IPO by offering 7 million shares at a price of US$1.00 per share to raise gross proceeds of US$7 million and 10,000,000 units at the offering price per unit for gross proceeds of US$10 million. “The additional US$17 million in capital adds to our healthy treasury, providing us with a solid foundation to build from and execute on our strategic plans for 2021 and beyond," HempFusion Wellness co-founder and CEO Dr Jason Mitchell said in a statement.

() announced Wednesday that it has secured base-load orders for the production of raw materials servicing the infrastructure marketplace at its Perry County Resources (PCR) mining complex. The Fishers, Indiana-based company has previously announced that its contractor has commenced production at the restructured PCR complex under its streamlined, low-cost operating model. American Resources said the secured commitments and contracts are for product that will be delivered to one of the largest steel companies in the world, as well as specialty alloy metal producers and industrial companies domestically and abroad.

Inc () announced Wednesday that it is about to make history. Based on its preliminary internal financial reporting for the fourth quarter of 2020, the Utah-based company said its unaudited quarterly revenue is anticipated to be the highest in its history and to surpass analyst estimates ranging from $24 million to $25.98 million. Co-Diagnostics said revenue for its 4Q, which ended December 31, is expected to exceed the highest estimate and to show 20%-25% growth over 3Q 2020 revenue of $21.82 million.

() provided its outlook for 2021, in which the company is aiming to commercialize its fully-compostable, plant-based capsules for use in Keurig Brewing Systems in the first half of the year. NEXE also said it is targeting the launch of its coffee capsules for use in Nespresso "original line" brewing systems by the second half of 2021.

Continue reading

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires

. () () unveiled significant expansion moves after the market close on Tuesday, announcing plans to acquire both Green Therapeutics LLC and 2750176 Ontario Inc., known as ALPS, and getting a new CEO in the process. Green Therapeutics is an award-winning, Nevada-based cannabis company with a strong brand portfolio of high-end dried flower and designer/luxury derivative products; ALPS is a global leader in facility design, construction management and (post) commissioning services to the horticultural sector. Terry Booth, currently a principal of ALPS, will become CEO of Australis at closing, taking over from Dr Duke Fu, who has been serving as Interim CEO since November 17, 2020.

(NYSEAMERICAN:AIM) (FRA:HXB2) has announced Wednesday that the active AMP-511 Expanded Access Program (EAP) has dosed its first coronavirus (COVID-19) “Long Hauler” patient with the drug Ampligen (rintatolimod). The company said the initial dosing marks a significant milestone in its efforts to develop an effective therapeutic for people suffering from post-COVID-19 infection chronic fatigue-like symptoms. Additional patients are in the process of being enrolled. 

() (OTCPINK:MWSNF) (FRA:MXR) has reported more encouraging drill results from its Sunday Creek project in Victoria, Australia, which show the potential for a widespread, gold-rich system. The latest assays come from two holes at the property, which lies in the famous Victorian Goldfields of Australia, and where ten holes have now been completed for 1,504 metres (m). Drilling will continue at the property from early this month. 

African Gold Group Inc () (OTCMKTS:AGGFF) (FRA:3A61) told investors it was on track to release an updated mineral resource for its flagship Kobada gold project in Mali early this year as the company released another round of positive drill assays and said it had extended drilling. So far, the company has sunk 6,258 metres of combined diamond drilling and reverse circulation drilling, with results continuing to show deeper than anticipated extensions of the orebody as well as additional mineralized zones outside the known ore zones.

Continue reading

Green Therapeutics is an award-winning, Nevada-based cannabis company with a strong brand portfolio of high-end dried flower and designer/luxury derivative products; ALPS is a global leader in facility design, construction management and (post) commissioning services to the horticultural sector

Terry Booth, currently a principal of ALPS, will become CEO of Australis at closing, taking over from Dr Duke Fu, who has been serving as Interim CEO since November 17, 2020

. () () (FRA:AC4) unveiled significant expansion moves after the market close on Tuesday, announcing plans to acquire both Green Therapeutics LLC and 2750176 Ontario Inc., known as ALPS, and getting a new CEO in the process. 

The company said it has entered into a non-binding term sheet dated January 4, 2020, with Green Therapeutics (GT) and the holders of the issued and outstanding membership interests of GT, setting forth the terms of a proposed transaction pursuant to which Australis will purchase 100% of the issued and outstanding membership interests in GT. 

Australis will pay to the holders of the GT, membership interests between C$9.5 million and C$10 million for 100% of the outstanding GT membership interests. 

READ: Australis taps cannabis finance veteran Jon Paul to CFO role, offers corporate update amid leadership transition

Prior to completing the acquisition, the group added, the parties have agreed to settle a previously announced legal dispute regarding the original May 2019 transaction, when Australis had acquired certain non-operational GT assets.

Continue reading

1933 Industries (CSE: TGIF- OTCQB: TGIFF) CEO Paul Rosen joined Steve Darling from Proactive with news the company has released their Q-1 financials which saw an increase in revenue of 12%.

Rosen also talked about the company’s margins which also saw a massive increase. Rosen also shared his thoughts on 2021 and how the recent U.S. election may have a big impact on the industry.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

Continue reading

Paul was previously CFO at PLUS Products, a CSE-listed hemp and cannabis edibles company with operations in California and Nevada

In November, AUSA began a leadership transition led by interim CEO Duke Fu

() (OTC:AUSAF) announced Wednesday that it has named cannabis and consumer goods veteran appointed Jon Paul its new CFO, effective January 1.

Paul was previously CFO at PLUS Products, a CSE-listed hemp and cannabis edibles company with operations in California and Nevada. He oversaw the company's IPO and was a key member of the team responsible for its 15-fold increase in revenue. 

Over his more than 40-year career, Paul has held several senior financial roles at public and private companies in the cannabis, consumer goods, wireless telecom and generic pharmaceutical industries.

READ: Australis Capital says new board of directors is ready to get to work optimizing cannabis assets

"Jon comes to us with a stellar track record in driving business performance across various sectors, including the US cannabis industry," Jason Dyck, chairperson of AUSA's compensation and nominating committee, said in a statement. "With his broad experience across multiple financial disciplines, including financial reporting, M&A, capital markets, corporate financial efficiency and operations, he is the ideal candidate to take on this key role as AUSA executes on its aggressive growth strategy. I look forward to working closely with Jon as we take AUSA to the next level."

Continue reading

With the goal of enhancing the user-experience, the group said the new website features more intuitive navigation and improved education to assist consumers select wellness products that suit their individual lifestyles and needs

Featuring a large selection of high-quality hemp and CBD products with specific outcomes and delivery formats, Canna Hemp aims to bring natural wellness to consumers across the United States

() (OTCQB:TGIFF), a vertically integrated cannabis consumer packaged goods company, has announced the launch of a new e-commerce website for its Canna Hemp brand of hemp and CBD wellness products. 

With the goal of enhancing the user-experience, the group said the new website features more intuitive navigation and improved education to assist consumers select wellness products that suit their individual lifestyles and needs. Featuring a large selection of high-quality hemp and CBD products with specific outcomes and delivery formats, Canna Hemp aims to bring natural wellness to consumers across the United States.

READ: 1933 Industries sees 1Q 2021 revenue climb 13% quarter over quarter on strong Nevada consumer demand

"Our new website reflects an immersive approach to online shopping. We aim to deliver the power of CBD to our consumers via an elevated experience, educating our visitors about the benefits of terpenes and adding a number of new features aimed at making the overall experience more impactful and user-friendly," Eugene Ruiz, president of 1933 Industries said in a statement.

"With a fresh look and feel, the hemp and CBD one-stop-shop showcases all our Canna Hemp brands, including our Canna Hemp X actions sports line," he added. "Canna Hemp stands as a trusted brand for its unwavering commitment to using only quality organic botanical ingredients that are free of synthetic chemicals, preservatives and additives. Canna Hemp infuses its products with high-grade, 100% all-natural hemp-derived CBD sourced from regulated suppliers in the US. Many of our products are made with TerpFX, our proprietary blend of terpenes designed to bring maximum benefits to your wellness routine."

Continue reading